SOLARA vs WOCKPHARMA: Stock Comparison

SOLARA ACTIVE PHA SCI vs WOCKHARDTUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. SOLARA ACTIVE PHA SCI shows a lower P/E, faster revenue growth and lower leverage, while WOCKHARDT shows a higher ROE, a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SOLARA leads 5; WOCKPHARMA leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SOLARAWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹3,077 Cr
₹33,908 Cr
P/E RatioSOLARA has the lower reading
0x
75.68x
P/B RatioSOLARA has the lower reading
2.45x
6.27x
EPSWOCKPHARMA has the higher reading
₹3.38
₹6.58
Book ValueContext only
₹260.24
₹325
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹33,908 Cr vs ₹3,077 Cr
P/E Ratio
SOLARA has a lower P/E
0x vs 75.68x
P/B Ratio
SOLARA has a lower P/B
2.45x vs 6.27x
EPS
WOCKPHARMA has higher earnings per share
₹6.58 vs ₹3.38
Revenue Growth (TTM YoY)
SOLARA has faster revenue growth
41.9% vs 26%
Qtr Sales Growth
SOLARA has stronger quarterly sales growth
0% vs -39.61%
Qtr Profit Growth
WOCKPHARMA has stronger quarterly profit growth
0% vs -4%
ROE
WOCKPHARMA has a higher ROE
10.28% vs -0.58%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSOLARAWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricSOLARAWOCKPHARMA
Live Price₹639.15₹2,088.7
Day Change1.48%7.08%
Volume3.97 L35.58 L
52-Week High₹712₹2,422.3
52-Week Low₹422₹1,086.7
Distance from 52W High-10.23%-13.77%

Valuation

MetricSOLARAWOCKPHARMA
Market Cap₹3,077 Cr₹33,908 Cr
P/E Ratio0x75.68x
P/B Ratio2.45x6.27x
EPS₹3.38₹6.58
Book Value₹260.24₹325
Dividend Yield0%0%

Growth

MetricSOLARAWOCKPHARMA
Revenue Growth (TTM YoY)41.9%26%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%-39.61%
Qtr Profit Growth-4%0%

Profitability & Leverage

MetricSOLARAWOCKPHARMA
ROE-0.58%10.28%
ROCE4.66%10.37%
Net Margin-0.54%3.3%
Operating Margin6.36%28.35%
Debt to Equity0.49x0.57x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSOLARAWOCKPHARMA
Promoter Holding41.93% 0.07 pp49.08%
FII Holding11.52% 0.19 pp7.22% 0.13 pp
DII Holding3.74% 0.04 pp9.24% 1.72 pp
Public Holding42.81% 0.08 pp34.44% 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SOLARA ACTIVE PHA SCI and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.